Industry Theaters

BTK Mutations and the Emergence of Treatment Resistance: Changing the CLL Landscape

Sponsored by AbbVie (Pharmacyclics)

For In-Person Participants Only

COVID-19: Protecting Vulnerable Populations

Sponsored by AstraZeneca

For In-Person Participants Only

Quality of Life, Burden of Illness, and Treatment Burden in Paroxysmal Nocturnal Hemoglobinuria: A Current Perspective on C5 Inhibitors

Sponsored by Genentech, A Member of the Roche Group

For In-Person Participants Only

The disease burden of transfusion dependent beta-thalassemia and approaches to cell and genetic therapy

Sponsored by Vertex Pharmaceuticals Inc.

For In-Person Participants Only

Classical Hematology: Looking into the Future

Sponsored by X4 Pharmaceutical

For In-Person Participants Only

In Pursuit of Healthier Red Blood Cells: The RISE UP Phase 2/3 Clinical Trial of Mitapivat in Sickle Cell Disease

Sponsored by Agios Pharmaceuticals, Inc.

For In-Person Participants Only

This session will include a patient perspective provided by Golie Lorenzo Green.

Emerging AstraZeneca Hematology Pipeline

Sponsored by AstraZeneca

For In-Person Participants

Gilead and Kite Oncology Pipeline

Sponsored by Gilead and Kite Oncology

For In-Person Participants Only